Biogen, Ginkgo Bioworks In Gene Therapy Collaboration Worth $120M
#biogen
#ginkgobioworks
#gene
3 years ago By Lawce — Biogen Inc (NASDAQ: BIIB) and Ginkgo Bioworks have entered into a gene therapy collaboration to develop a next-generation adeno-associated virus (AAV)-base